These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7298740)

  • 1. Measurement of sulindac and its metabolites in human plasma and urine by high-performance liquid chromatography.
    Swanson BN; Boppana VK
    J Chromatogr; 1981 Sep; 225(1):123-30. PubMed ID: 7298740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of sulindac and metabolites in plasma and urine by high-performance liquid chromatography.
    Stubbs RJ; Ng LL; Entwistle LA; Bayne WF
    J Chromatogr; 1987 Jan; 413():171-80. PubMed ID: 3558666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical methods for the determination of sulindac and metabolites in plasma, urine, bile, and gastric fluid by liquid chromatography using ultraviolet detection.
    Musson DG; Vincek WC; Constanzer ML; Detty TE
    J Pharm Sci; 1984 Sep; 73(9):1270-3. PubMed ID: 6491950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatographic determination of sulindac and metabolites in serum.
    Clark CR; McMillian CL; Hoke JF; Campagna KD; Ravis WR
    J Chromatogr Sci; 1987 Jun; 25(6):247-51. PubMed ID: 3611280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatography of sulindac and its sulphone and sulphide metabolites in plasma.
    Grgurinovich N
    J Chromatogr; 1987 Feb; 414(1):211-6. PubMed ID: 3571386
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotransformation of sulindac in end-stage renal disease.
    Gibson TP; Dobrinska MR; Lin JH; Entwistle LA; Davies RO
    Clin Pharmacol Ther; 1987 Jul; 42(1):82-8. PubMed ID: 3595070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of sulindac and its metabolites in serum by high-performance liquid chromatography.
    Dusci LJ; Hackett LP
    J Chromatogr; 1979 Apr; 171():490-3. PubMed ID: 546862
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of sulindac and its metabolites in human serum by reversed-phase high-performance liquid chromatography using on-line post-column ultraviolet irradiation and fluorescence detection.
    Siluveru M; Stewart JT
    J Chromatogr B Biomed Appl; 1995 Nov; 673(1):91-6. PubMed ID: 8925079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of graded oral doses of sulindac in man.
    Mattila J; Mäntylä R; Vuorela A; Lamminsivu U; Männistö P
    Arzneimittelforschung; 1984; 34(2):226-9. PubMed ID: 6539116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual variability in concentrations of urinary sulindac sulfide.
    Brandli DW; Sarkissian E; Ng SC; Paulus HE
    Clin Pharmacol Ther; 1991 Dec; 50(6):650-5. PubMed ID: 1752108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulindac metabolism: the importance of an intact colon.
    Strong HA; Warner NJ; Renwick AG; George CF
    Clin Pharmacol Ther; 1985 Oct; 38(4):387-93. PubMed ID: 4042521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thin layer and densitometry for quantitative determination of drugs. I. Identification and determination of sulindac and its metabolites in plasma].
    Corti P; Lencioni E; Zamboni R; Lazzeri L
    Boll Chim Farm; 1983 May; 122(5):229-36. PubMed ID: 6639782
    [No Abstract]   [Full Text] [Related]  

  • 13. Computerized mass spectrometric assay for sulindac and its metabolites in human plasma.
    Walker RW; Gruber VF; Rosenberg A; Wolf FJ; VandenHeuvel WJ
    Anal Biochem; 1979 Jun; 95(2):579-86. PubMed ID: 453542
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac.
    Sitar DS; Owen JA; MacDougall B; Hunter T; Mitenko PA
    Clin Pharmacol Ther; 1985 Aug; 38(2):228-34. PubMed ID: 4017423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of acetaminophen metabolites in urine by high-performance liquid chromatography with UV and amperometric detection.
    Wilson JM; Slattery JT; Forte AJ; Nelson SD
    J Chromatogr; 1982 Feb; 227(2):453-62. PubMed ID: 7061657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterohepatic circulation of sulindac and metabolites.
    Dujovne CA; Pitterman A; Vincek WC; Dobrinska MR; Davies RO; Duggan DE
    Clin Pharmacol Ther; 1983 Feb; 33(2):172-7. PubMed ID: 6822030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimethyl sulfoxide inhibits bioactivation of sulindac.
    Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
    J Lab Clin Med; 1983 Jul; 102(1):95-101. PubMed ID: 6854139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and dialyzability of sulindac and metabolites in patients with end-stage renal failure.
    Ravis WR; Diskin CJ; Campagna KD; Clark CR; McMillian CL
    J Clin Pharmacol; 1993 Jun; 33(6):527-34. PubMed ID: 8366178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption of sulindac from a novel (Pro-SorbTM) liquid formulation.
    Kanfer I; Brown C; Konings M; Swarbrick J
    Biopharm Drug Dispos; 1996 Apr; 17(3):209-21. PubMed ID: 8983396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capillary electrophoresis combining field-amplified sample stacking and electroosmotic flow suppressant for analysis of sulindac and its two metabolites in plasma.
    Chen YL; Jong YJ; Wu SM
    J Chromatogr A; 2006 Jun; 1119(1-2):176-82. PubMed ID: 16530777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.